- Report
- November 2025
- 196 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 191 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 465 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 277 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 354 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 277 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 383 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 376 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 381 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 278 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 494 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 365 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 271 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 278 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 274 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 471 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 384 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 93 Pages
Global
From €5023EUR$5,600USD£4,428GBP
- Report
- November 2025
- 181 Pages
Global
From €5247EUR$5,850USD£4,626GBP
- Report
- November 2025
- 360 Pages
Global
From €5247EUR$5,850USD£4,626GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more